Diets, Foods and Food Components Effect on Dyslipidemia
Dyslipidemia, and particularly hypercholesterolemia, remains a main cardiovascular disease risk factor, partly reversible with the improvement of life-style, including dietary, habits. Even when a pharmacological treatment is begun, dietary support to lipid-lowering is always desired. This book will...
Saved in:
| Other Authors: | , , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_76758 | ||
| 005 | 20220111 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-1239-6 | ||
| 020 | |a 9783036512389 | ||
| 020 | |a 9783036512396 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1239-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MBN |2 bicssc | |
| 100 | 1 | |a Fogacci, Federica |4 edt | |
| 700 | 1 | |a Cicero, Arrigo |4 edt | |
| 700 | 1 | |a Borghi, Claudio |4 edt | |
| 700 | 1 | |a Fogacci, Federica |4 oth | |
| 700 | 1 | |a Cicero, Arrigo |4 oth | |
| 700 | 1 | |a Borghi, Claudio |4 oth | |
| 245 | 1 | 0 | |a Diets, Foods and Food Components Effect on Dyslipidemia |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (300 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Dyslipidemia, and particularly hypercholesterolemia, remains a main cardiovascular disease risk factor, partly reversible with the improvement of life-style, including dietary, habits. Even when a pharmacological treatment is begun, dietary support to lipid-lowering is always desired. This book will provide a selection of new evidence on the possible lipid-lowering effects of some dietary and medicinal plant components, reporting some interesting reviews, experimental data and results from clinical trials. The book is adapted for experts in nutrition but also for all scientists involved in cardiovascular disease prevention. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Public health & preventive medicine |2 bicssc | |
| 653 | |a beta-glucan | ||
| 653 | |a fiber | ||
| 653 | |a lipid profile | ||
| 653 | |a cholesterol | ||
| 653 | |a intestinal function | ||
| 653 | |a green tea | ||
| 653 | |a epigallocatechin gallate | ||
| 653 | |a chitosan | ||
| 653 | |a microspheres | ||
| 653 | |a Eudragit | ||
| 653 | |a metabolic diseases | ||
| 653 | |a LCD score | ||
| 653 | |a CHNS | ||
| 653 | |a dyslipidemia | ||
| 653 | |a dietary factor | ||
| 653 | |a plant based | ||
| 653 | |a animal based | ||
| 653 | |a Chinese adults | ||
| 653 | |a nutraceuticals | ||
| 653 | |a PCSK9 | ||
| 653 | |a SREBP | ||
| 653 | |a HNF1α | ||
| 653 | |a berberine | ||
| 653 | |a metabolic syndrome | ||
| 653 | |a plant extracts | ||
| 653 | |a natural antioxidant | ||
| 653 | |a polyphenols | ||
| 653 | |a bergamot | ||
| 653 | |a blackcurrant | ||
| 653 | |a liver steatosis | ||
| 653 | |a ovariectomized | ||
| 653 | |a phytoestrogen | ||
| 653 | |a vitamin B12 | ||
| 653 | |a healthy | ||
| 653 | |a Saudi Arabia | ||
| 653 | |a serum cholesterol | ||
| 653 | |a serum triglycerides | ||
| 653 | |a serum low density lipoprotein | ||
| 653 | |a serum high density lipoprotein | ||
| 653 | |a dietary intake | ||
| 653 | |a lifestyle | ||
| 653 | |a black raspberry | ||
| 653 | |a excessive choline | ||
| 653 | |a TMAO | ||
| 653 | |a hypercholesterolemia | ||
| 653 | |a hepatic inflammation | ||
| 653 | |a review | ||
| 653 | |a CVD | ||
| 653 | |a cardiovascular health | ||
| 653 | |a dietary fats | ||
| 653 | |a dietary fiber | ||
| 653 | |a phytosterols | ||
| 653 | |a plant-based diet | ||
| 653 | |a dietary pattern | ||
| 653 | |a sustainability | ||
| 653 | |a propolis | ||
| 653 | |a formononetin | ||
| 653 | |a gastric ulcer | ||
| 653 | |a rats | ||
| 653 | |a Chrysanthemum morifolium Ramat leaves | ||
| 653 | |a obesity | ||
| 653 | |a lipidomics | ||
| 653 | |a liquid chromatography tandem mass spectrometry | ||
| 653 | |a phospholipid | ||
| 653 | |a sphingolipid | ||
| 653 | |a monacolins | ||
| 653 | |a LDL-cholesterol | ||
| 653 | |a red yeast rice | ||
| 653 | |a clinical trial | ||
| 653 | |a endothelial function | ||
| 653 | |a alpha-linolenic acid | ||
| 653 | |a flaxseed | ||
| 653 | |a lipids | ||
| 653 | |a omega-3 | ||
| 653 | |a walnuts | ||
| 653 | |a type 2 diabetes mellitus | ||
| 653 | |a glibenclamide | ||
| 653 | |a omega-3 fatty acids | ||
| 653 | |a high fat diet | ||
| 653 | |a transcription factors | ||
| 653 | |a streptozotocin | ||
| 653 | |a Armolipid Plus® | ||
| 653 | |a nutraceutical | ||
| 653 | |a supplementation | ||
| 653 | |a blood pressure | ||
| 653 | |a fasting plasma glucose | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4207 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76758 |7 0 |z DOAB: description of the publication |